WaveMan
WaveMan · SEC 13F
Data Collective IV GP, LLC 13F holdings
> Search tickers & screens ⌘K
LIVE

Data Collective IV GP, LLC 13F holdings

Data Collective IV GP, LLC reported 4 positions with a total reported value of $78.6M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: EVLV Evolv Technologies Holdings, Inc. (33.9%), HQ Horizon Quantum Holdings Ltd (32.3%), RXRX Recursion Pharmaceuticals, Inc. (27.8%), DFTX Definium Therapeutics, Inc. (MindMed) (6.0%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.

Email me when Data Collective IV GP, LLC files its 13F

A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.

Top holdings

4 largest of 4 positions · reported value as of 2026-06-30
HoldingSharesReported value% of portfolio
EVLV Evolv Technologies Holdings, Inc.4,590,000$26.6M33.9%
HQ Horizon Quantum Holdings Ltd915,198$25.4M32.3%
RXRX Recursion Pharmaceuticals, Inc.5,941,120$21.8M27.8%
DFTX Definium Therapeutics, Inc. (MindMed)100,350$4.7M6.0%
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES

New positions this quarter

Held at 2026-06-30, not at 2026-03-31 · 0 in all · reported value as of 2026-06-30

No new positions.

Sold out

Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31

No positions were sold out.

Biggest increases and decreases

Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30

Increases

No position was increased.

Decreases

No position was decreased.

CIK 1664974 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms